Canaan IX L.P. Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Canaan IX L.P..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Canaan IX L.P.. Canaan IX L.P. is Director in CytomX Therapeutics, Inc. ($CTMX) and 10% Owner in TheRealReal, Inc. ($REAL) and 10% Owner in ARVINAS INC. ($ARVN).

Latest Insider Trading Transactions of Canaan IX L.P.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ARVN, CTMX, REAL

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Oct 15 2020ARVNARVINAS, INC.Canaan IX L.P.10% OwnerSellJ0.00400,00003,589,5544 M to 3.6 M (-10.03 %)
Jul 21 2020ARVNARVINAS, INC.Canaan IX L.P.10% OwnerSellJ0.00500,00003,989,5544.5 M to 4 M (-11.14 %)
Jan 16 2020REALTheRealReal, Inc.Canaan IX L.P.10% OwnerSellJ0.00881,00007,925,9198.8 M to 7.9 M (-10.00 %)
Jul 02 2019REALTheRealReal, Inc.Canaan IX L.P.10% OwnerOption ExerciseC0.00427,02000
Jul 02 2019REALTheRealReal, Inc.Canaan IX L.P.10% OwnerOption ExerciseC0.00427,02000
Jul 02 2019REALTheRealReal, Inc.Canaan IX L.P.10% OwnerOption ExerciseC0.00654,29800
Jul 02 2019REALTheRealReal, Inc.Canaan IX L.P.10% OwnerOption ExerciseC0.00654,29800
Jul 02 2019REALTheRealReal, Inc.Canaan IX L.P.10% OwnerOption ExerciseC0.001,790,58000
Jul 02 2019REALTheRealReal, Inc.Canaan IX L.P.10% OwnerOption ExerciseC0.001,790,58000
Jul 02 2019REALTheRealReal, Inc.Canaan IX L.P.10% OwnerOption ExerciseC0.004,120,82300
Jul 02 2019REALTheRealReal, Inc.Canaan IX L.P.10% OwnerOption ExerciseC0.004,120,82300
Jul 02 2019REALTheRealReal, Inc.Canaan IX L.P.10% OwnerOption ExerciseC0.002,214,82500
Jul 02 2019REALTheRealReal, Inc.Canaan IX L.P.10% OwnerOption ExerciseC0.002,214,82500
Jul 02 2019REALTheRealReal, Inc.Canaan IX L.P.10% OwnerOption ExerciseC0.007,398,27200
Jul 02 2019REALTheRealReal, Inc.Canaan IX L.P.10% OwnerOption ExerciseC0.007,398,27200
Jul 02 2019REALTheRealReal, Inc.Canaan IX L.P.10% OwnerBuyC0.00213,51008,806,9198.6 M to 8.8 M (+2.48 %)
Jul 02 2019REALTheRealReal, Inc.Canaan IX L.P.10% OwnerBuyC0.00213,51008,806,9198.6 M to 8.8 M (+2.48 %)
Jul 02 2019REALTheRealReal, Inc.Canaan IX L.P.10% OwnerBuyC0.00327,14908,593,4098.3 M to 8.6 M (+3.96 %)
Jul 02 2019REALTheRealReal, Inc.Canaan IX L.P.10% OwnerBuyC0.00327,14908,593,4098.3 M to 8.6 M (+3.96 %)
Jul 02 2019REALTheRealReal, Inc.Canaan IX L.P.10% OwnerBuyC0.00895,29008,266,2607.4 M to 8.3 M (+12.15 %)
Jul 02 2019REALTheRealReal, Inc.Canaan IX L.P.10% OwnerBuyC0.00895,29008,266,2607.4 M to 8.3 M (+12.15 %)
Jul 02 2019REALTheRealReal, Inc.Canaan IX L.P.10% OwnerBuyC0.002,060,41107,370,9705.3 M to 7.4 M (+38.80 %)
Jul 02 2019REALTheRealReal, Inc.Canaan IX L.P.10% OwnerBuyC0.002,060,41107,370,9705.3 M to 7.4 M (+38.80 %)
Jul 02 2019REALTheRealReal, Inc.Canaan IX L.P.10% OwnerBuyC0.001,107,41205,310,5594.2 M to 5.3 M (+26.35 %)
Jul 02 2019REALTheRealReal, Inc.Canaan IX L.P.10% OwnerBuyC0.001,107,41205,310,5594.2 M to 5.3 M (+26.35 %)
Jul 02 2019REALTheRealReal, Inc.Canaan IX L.P.10% OwnerBuyC0.003,699,13604,203,147504 K to 4.2 M (+733.94 %)
Jul 02 2019REALTheRealReal, Inc.Canaan IX L.P.10% OwnerBuyC0.003,699,13604,203,147504 K to 4.2 M (+733.94 %)
Jun 12 2019ARVNARVINAS, INC.Canaan IX L.P.10% OwnerSellJ0.00500,00004,489,5545 M to 4.5 M (-10.02 %)
Oct 03 2018ARVNARVINAS INC.Canaan IX L.P.10% OwnerOption ExerciseC0.002,209,83300
Oct 03 2018ARVNARVINAS INC.Canaan IX L.P.10% OwnerOption ExerciseC0.004,462,83700
Oct 03 2018ARVNARVINAS INC.Canaan IX L.P.10% OwnerOption ExerciseC0.009,543,38700
Oct 03 2018ARVNARVINAS INC.Canaan IX L.P.10% OwnerBuyC0.004,989,55404,989,5540 to 5 M
Mar 28 2017CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellJ0.00750,00002,494,3813.2 M to 2.5 M (-23.12 %)
Dec 01 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellJ0.00400,00003,244,3813.6 M to 3.2 M (-10.98 %)
Dec 01 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS11.1822,086247,0083,644,3813.7 M to 3.6 M (-0.60 %)
Nov 28 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS11.3320,840236,1423,666,4673.7 M to 3.7 M (-0.57 %)
Nov 28 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS11.796,72979,3413,687,3073.7 M to 3.7 M (-0.18 %)
Nov 28 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS11.8410,890128,9213,694,0363.7 M to 3.7 M (-0.29 %)
Nov 22 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS11.7142,550498,0783,704,9263.7 M to 3.7 M (-1.14 %)
Nov 21 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS11.7213,548158,7853,747,4763.8 M to 3.7 M (-0.36 %)
Nov 21 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS11.6412,805149,0853,761,0243.8 M to 3.8 M (-0.34 %)
Nov 21 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS11.5018,971218,2183,773,8293.8 M to 3.8 M (-0.50 %)
Nov 16 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS11.5518,517213,9533,792,8003.8 M to 3.8 M (-0.49 %)
Nov 16 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS11.4833,064379,4763,811,3173.8 M to 3.8 M (-0.86 %)
Nov 14 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS11.2123,744266,0563,844,3813.9 M to 3.8 M (-0.61 %)
Nov 14 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS11.2035,391396,4613,868,1253.9 M to 3.9 M (-0.91 %)
Nov 14 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS11.0727,135300,3903,903,5163.9 M to 3.9 M (-0.69 %)
Nov 10 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS11.0313,730151,4983,930,6513.9 M to 3.9 M (-0.35 %)
Oct 12 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellJ0.00300,00003,944,3814.2 M to 3.9 M (-7.07 %)
Jun 10 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS10.012,70027,0274,244,3814.2 M to 4.2 M (-0.06 %)
Jun 10 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS10.0622,842229,7914,247,0814.3 M to 4.2 M (-0.53 %)
Jun 10 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS10.0822,885230,6814,269,9234.3 M to 4.3 M (-0.53 %)
Jun 08 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS10.039,73197,6024,292,8084.3 M to 4.3 M (-0.23 %)
Jun 08 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS10.01101,7671,018,6884,302,5394.4 M to 4.3 M (-2.31 %)
Jun 06 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS10.8318,428199,5754,404,3064.4 M to 4.4 M (-0.42 %)
Jun 06 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS10.7941,193444,4724,422,7344.5 M to 4.4 M (-0.92 %)
Jun 02 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS10.7522,463241,4774,463,9274.5 M to 4.5 M (-0.50 %)
Jun 01 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS10.6025,082265,8694,486,3904.5 M to 4.5 M (-0.56 %)
May 27 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS10.4339,887416,0214,511,4724.6 M to 4.5 M (-0.88 %)
May 27 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS10.0211,456114,7894,551,3594.6 M to 4.6 M (-0.25 %)
May 25 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS10.001,20012,0004,562,8154.6 M to 4.6 M (-0.03 %)
May 25 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS10.1012,053121,7354,564,0154.6 M to 4.6 M (-0.26 %)
May 23 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS10.096,18762,4274,576,0684.6 M to 4.6 M (-0.14 %)
May 23 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellS10.142,50025,3504,582,2554.6 M to 4.6 M (-0.05 %)
Apr 26 2016CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorSellJ0.00300,00004,584,7554.9 M to 4.6 M (-6.14 %)
Oct 16 2015CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorOption ExerciseC0.001,318,41800
Oct 16 2015CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorOption ExerciseC0.003,566,33700
Oct 16 2015CTMXCytomX Therapeutic ...Canaan IX L.P.DirectorBuyC0.004,884,75504,884,7550 to 4.9 M

Page:   1